MRVI — Maravai Lifesciences Holdings Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapNeutral

Annual balance sheet for Maravai Lifesciences Holdings, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	236	551	632	575	322
Net Total Accounts Receivable
Net Total Receivables	51.2	118	147	55.7	38.5
Total Inventory
Prepaid Expenses
Total Current Assets	332	740	848	700	429
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	101	95.4	117	223	217
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets	1,271	1,918	2,282	1,487	1,008
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	131	93.8	110	87.5	57
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	1,182	1,603	1,737	1,071	683
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	88.5	315	545	417	325
Total Liabilities & Shareholders' Equity	1,271	1,918	2,282	1,487	1,008
Total Common Shares Outstanding